TrialBlood2025

Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies.

Katelyn Purvis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.